Dixon shares fall up to 2.5% as brokerages flag hurdles in new mobile incentive scheme
India’s Rs 62,500 crore Mobile Phone Manufacturing Scheme could add 14–22 bps to Dixon’s EBITDA margin through higher output and local sourcing, Kotak said. CLSA, however, flagged challenges in meeting export-linked eligibility requirements.
What happened
Dixon Technologies (India) Ltd. · Dixon shares declined after brokerages assessed India’s new mobile manufacturing incentive scheme. CLSA flagged export-linked
Key facts
- Shares fell as much as 2.5% (Rs 366) to Rs 14,484
- Mobile Phone Manufacturing Scheme outlay: Rs 62,500 crore
- Manufacturing incentives: 2.25% to 5%
- Domestic-sourcing incentive: up to 1.5%
- Existing brands require Rs 5,000 crore annual sales growth above FY 2025-26
- New brands must reach Rs 10,000 crore annual sales before growth requirement
- Kotak estimates 14-22 basis points EBITDA-margin addition
- Expected cumulative mobile production: Rs 39 lakh crore
- Expected direct jobs: around 60,000
Why this matters
The incentive framework strengthens the case for partnerships or acquisitions that add local components capacity and export-market access.
What to watch
- Final scheme guidelines, eligibility definitions and incentive disbursement timeline.
- Dixon’s disclosed export order book, customer commitments and mobile manufacturing volume growth.
- Quarterly mobile-segment EBITDA margin, incentive receivables and working-capital movement.
- Evidence of higher domestic component sourcing and progress in non-SMT/component manufacturing.
- Handset customer concentration, pricing negotiations and any production allocation shifts by major brands.
- Government verification, approval or rejection of incentive claims.
- Seek clarity from management on scheme eligibility, export baseline assumptions, localization requirements and the timing of incentive recognition.
- Accelerate contracts with handset brands that can route export volumes through Indian manufacturing facilities.
- Expand local sourcing of key components to raise domestic value addition and reduce import dependence.
- Sequence capacity and component capex against confirmed customer volumes to limit underutilization and working-capital strain.
- Provide investors with scenario-based guidance separating operating margin improvement from policy-incentive benefits.